Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
-
Field
-
EdgeOnVespa (NORTE2030-FEDER-02972100), co-funded by the European Regional Development Fund (ERDF) through the financial support of the Portuguese Innovation and Digital Transition Program (PITD 2030
-
course, Article 6, Regulation No. 950/2019 of the Fundação para a Ciência e a Tecnologia, in Biological Sciences, in the frame of the R&D project ReNUT - Development of hypoallergenic almond-based flours
-
at the time of signing the contract. or - Holder of an academic degree enrolled in a non-academic degree course integrated in the educational project of a higher education institution, developed in association
-
(Article 6 of FCT Regulation no. 950/2019), in the frame of the R&D project “ECOcrete3D – Development of new concrete formulations incorporating municipal solid waste incineration residues
-
August; FCT, IP Research Grant Regulation, approved by Regulation N.º 234/2012, published in the II Series of the Diário da República of June 25, 2012, amended and republished by Regulation No. 326/2013
-
, aiming the consolidation of their scientific training through the development of research works leading to the attainment of the respective academic degree, whether integrated or not in R&D projects
-
at the time of signing the contract. or - Holder of an academic degree enrolled in a non-academic degree course integrated in the educational project of a higher education institution, developed in association
-
project of a higher education institution, developed in association or cooperation with one or more R&D units. Note: In the case of masters who are enrolled in non-academic degree courses, the scholarship
-
FCT code 2023.17217.ICDT and DOI https://doi.org/10.54499/2023.17217.ICDT . , funded by COMPETE 2030 by Portugal 2030, and by the European Union, financial support from national funds/OE through
-
Centr (NCN) as part of the SONATA 20 competition, project no. 2024/55/D/NZ5/03003, entitled „A gene with many faces - a model of severe congenital neutropenia in patient- derived iPS cells to elucidate